Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/MORPHOSYS-AG-436425/news/MorphoSys-gibt-Zulassung-von-Tremfya-R-Guselkumab-in-Japan-zur-Behandlung-von-palmoplantarer-Pu-27659182/?utm_source=whatsapp&utm_medium=social&utm_campaign=share